Skip to main content
. 2013 Nov 28;110(3):679–685. doi: 10.1038/bjc.2013.744

Figure 3.

Figure 3

Bladder cancer-specific survival analysis.Data are shown for 414 NMIBC patients with low EpCAM (<24 pg mg−1) and 48 NMIBC patients with high EpCAM (>24 pg mg−1) and 85 MIBC patients with low EpCAM (<24 pg mg−1) and 54 NMIBC patients with high EpCAM (<24 pg mg−1).